|
Market Cap (5-Jun) $13,719,451 (1,617th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 431,146 |
Shortsold (21-Jul) 380,000 (0.14%) (384th) |
|
52w High $0.098 |
52w Low $0.026 |
P/E - |
EPS -0.02 |
IMC released this announcement to the ASX on 25 January 2023, 9:30. The announcement is not marked as price sensitive, and is 2 page(s) in length and 252.86kb in size.
You can view all announcements from IMC and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMC was 0.002% short sold according to ASIC data. It was ranked the 616th most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.142% of total shares short sold as of the latest reported data (21 July 2025).
| Other Recent Announcements from IMC | |
|---|---|
| Immuron Chairman Transition | 30 June 2023, 11:03 |
| Letter to Shareholders | 22 June 2023, 8:27 |
| Immuron CEO, Steven Lydeamore presents at LD Micro | 7 June 2023, 8:26 |
| Immuron and US NMRC respond to CampETEC FDA Clinical Hold | 25 January 2023, 9:30 |
| US DOD Travelan Clinical Recruitment Milestone | 18 January 2023, 14:07 |
| Immuron Receives European Patent on Drug Composition | 17 January 2023, 9:44 |
| Change in substantial holding | 30 December 2022, 8:23 |
You must be logged in to post a reply.
Immuron 